Al-Namaeh M. Ocular manifestations of COVID-19.
Ther Adv Ophthalmol 2022;
14:25158414221083374. [PMID:
35434520 PMCID:
PMC9008819 DOI:
10.1177/25158414221083374]
[Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2021] [Accepted: 02/04/2022] [Indexed: 12/13/2022] Open
Abstract
COVID-19 is a disease caused by a SARS-CoV-2 viral infection, a disease that was
first detected in December 2019 in Wuhan, Hubei Province, China. COVID-19,
formerly known as 2019 Novel Coronavirus (2019-nCoV) respiratory disease, was
officially named COVID-19 by the World Health Organization (WHO) in February
2020. By 25 May 2021, there were 33,579,116 confirmed cases with 599,109
COVID-19 deaths worldwide. The purpose of this review article is to provide an
update on what is currently known about COVID-19 ocular symptoms in adults, the
elderly, and children in the literature. Finally, this article will review the
eye protection precautions that should be implemented in our clinics. To assess
the current literature, PubMed was searched from December 2019 to 25 May 2021.
Randomized trials, observational studies, case series or case reports, letters
of research, and letters to editors were selected for confirmed cases of
COVID-19. According to current scientific literature since the outbreak in
December 2019, 205 articles have been published. Conjunctivitis, conjunctival
hyperemia, and chemosis have been reported in adults with COVID-19. There have
been few studies on children and elderly patients, and further research in these
age groups is needed. Finally, wearing eye protection when seeing patients on a
daily basis during the pandemic is essential.
Collapse